<List><item><source>MED</source><extId>30026686</extId><pmcid>PMC6041410</pmcid><annotations><annotation><prefix>ials.gov identifier </prefix><exact>NCT00028262</exact><postfix>) for the treatment </postfix><tags><tag><name>NCT00028262</name><uri>http://identifiers.org/clinicaltrials/NCT00028262</uri></tag></tags><id>http://europepmc.org/articles/PMC6041410#europepmc-b9afb0d4786d63a3f085b81d63c078b1</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>l with Fenretinide (</prefix><exact>NCT00429936</exact><postfix>) did not show effic</postfix><tags><tag><name>NCT00429936</name><uri>http://identifiers.org/clinicaltrials/NCT00429936</uri></tag></tags><id>http://europepmc.org/articles/PMC6041410#europepmc-a215299833a6e3b496bdde4bf7016171</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ial with Emixustat (</prefix><exact>NCT01002950</exact><postfix>) showed a biologica</postfix><tags><tag><name>NCT01002950</name><uri>http://identifiers.org/clinicaltrials/NCT01002950</uri></tag></tags><id>http://europepmc.org/articles/PMC6041410#europepmc-e7027e528959ef88702455465af3d8eb</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>